Atlas Trials

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

Clinical trial NCT00963495 · TERMINATED

Trial details

NCT number
NCT00963495
Sponsor
University Health Network, Toronto
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaMyelodysplasiaLymphoma, Non-HodgkinHodgkin's LymphomaMultiple Myeloma
Start date
2009-08-01
Primary completion
2013-09-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.